Latest Updates IBA, Belgian company and worldwide leader in proton therapy systems opens its Japanese subsidiary in Tokyo

IBA (Ion Beam Applications) is a Belgian company founded in 1986 as a spin-off of the Cyclotron Research Center of the Catholic University of Louvain-la-Neuve (UCL, Belgium). IBA is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has 40+ systems in operations or installation across the world. The company is listed on the pan-European stock exchange NYSE EURONEXT and boasts the world's top share (over 50%) in the manufacturer of proton therapy equipment. The IBA branches are located in the United States, China, Germany and sell products and maintenance services in North America, Europe, Latin America, CIS, Asia and the Pacific region.